In what is considered to be the biggest initial public offering (IPO) by a pharmaceutical firm in India, Gland Pharma's Chinese promoters Fosun Pharma and other shareholders will be offering 43.2 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈